Bachem and Jitsubo CO., LTD. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s Molecular HivingTM technology. Under the License agreement, Jitsubo will…
A remarkable 2-part PBS News Hour story exclusively dedicated to AMR The antibiotics industry has suffered an alarming collapse that has become even more…
AM Vaccination: PepID – Bioinformatics for the Development of Immune Diagnostics and Vaccines: Combining Comparative Genomics and Computational Analyses of Pathogen Genomes with High…
bye bye
A remarkable 2-part PBS News Hour story exclusively dedicated to AMR COVID-19 can be accompanied by secondary bacterial infections with deadly consequences. But the…
AMR Stakeholder Profile Bacteromic Sp. z o.o Focus area/active in: Diagnostics Company/Organisation type: Other About:BacterOMIC takes antibiotic susceptibility testing (AST) to the next level…
AMR Stakeholder Profile Collaborative Drug Discovery Focus area/active in: Therapeutics Company/Organisation type: Industry About: Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively…
AMR Stakeholder Profile BACHEM AG Focus area/active in: Animal Health, One Health, Diagnostics, Therapeutics Company/Organisation type: Industry About:The Swiss based Bachem Group is a public, innovation-driven…
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent infections that cause life-threatening pneumonia and other deadly infections. CARB-X is…